ARS Pharmaceuticals, Inc. (SPRY) Retained earnings

annual retained earnings:

-$123.31M+$8.00M(+6.09%)
December 31, 2024

Summary

  • As of today (September 8, 2025), SPRY annual retained earnings is -$123.31 million, with the most recent change of +$8.00 million (+6.09%) on December 31, 2024.
  • During the last 3 years, SPRY annual retained earnings has fallen by -$81.05 million (-191.80%).
  • SPRY annual retained earnings is now -209.66% below its all-time high of -$39.82 million, reached on December 1, 2018.

Performance

SPRY Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

quarterly retained earnings:

-$202.13M-$44.88M(-28.54%)
June 30, 2025

Summary

  • As of today (September 8, 2025), SPRY quarterly retained earnings is -$202.13 million, with the most recent change of -$44.88 million (-28.54%) on June 30, 2025.
  • Over the past year, SPRY quarterly retained earnings has dropped by -$48.02 million (-31.16%).
  • SPRY quarterly retained earnings is now -216.88% below its all-time high of -$63.79 million, reached on December 1, 2019.

Performance

SPRY quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

SPRY Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+6.1%-31.2%
3 y3 years-191.8%+12.2%
5 y5 years-93.3%-

SPRY Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-191.8%+6.1%-120.0%+18.5%
5 y5-year-191.8%+6.1%-120.0%+18.5%
alltimeall time-209.7%+6.1%-216.9%+18.5%

SPRY Retained earnings History

DateAnnualQuarterly
Jun 2025
-
-$202.13M(+28.5%)
Mar 2025
-
-$157.25M(+27.5%)
Dec 2024
-$123.31M(-6.1%)
-$123.31M(-28.8%)
Sep 2024
-
-$173.24M(+12.4%)
Jun 2024
-
-$154.11M(+8.8%)
Mar 2024
-
-$141.59M(+7.8%)
Dec 2023
-$131.30M(+70.7%)
-$131.30M(+5.8%)
Sep 2023
-
-$124.14M(+13.6%)
Jun 2023
-
-$109.27M(+18.9%)
Mar 2023
-
-$91.90M(-63.0%)
Dec 2022
-$76.94M
-
DateAnnualQuarterly
Sep 2022
-
-$248.14M(+7.8%)
Jun 2022
-
-$230.27M(+9.2%)
Mar 2022
-
-$210.84M(+13.2%)
Dec 2021
-$42.26M(-56.3%)
-
Dec 2021
-
-$186.21M(+14.4%)
Sep 2021
-
-$162.75M(+16.2%)
Jun 2021
-
-$140.10M(+21.2%)
Mar 2021
-
-$115.60M(+19.5%)
Dec 2020
-$96.73M(+51.7%)
-$96.73M(+51.7%)
Dec 2019
-$63.79M(+60.2%)
-$63.79M
Dec 2018
-$39.82M
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual retained earnings?
  • What is the all time high annual retained earnings for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual retained earnings year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly retained earnings?
  • What is the all time high quarterly retained earnings for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

What is ARS Pharmaceuticals, Inc. annual retained earnings?

The current annual retained earnings of SPRY is -$123.31M

What is the all time high annual retained earnings for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual retained earnings is -$39.82M

What is ARS Pharmaceuticals, Inc. annual retained earnings year-on-year change?

Over the past year, SPRY annual retained earnings has changed by +$8.00M (+6.09%)

What is ARS Pharmaceuticals, Inc. quarterly retained earnings?

The current quarterly retained earnings of SPRY is -$202.13M

What is the all time high quarterly retained earnings for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$63.79M

What is ARS Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

Over the past year, SPRY quarterly retained earnings has changed by -$48.02M (-31.16%)
On this page